文献速递血液淋巴病理细胞病理与分子病理

原发黏膜CD30阳性T细胞淋巴组织增殖性疾病的临床病理特征

[Clinicopathological features of primary mucosal CD30-positive T-cell lymphoproliferative disorders].
PubMed 文献 · Zhonghua Bing Li Xue Za Zhi · 2024-01-01

回顾性分析8例原发黏膜CD30阳性T细胞淋巴组织增殖性疾病,7例位于口腔黏膜、1例肛管黏膜,形态谱系宽,CD30均匀强阳性而ALK和CD56阴性,EBER均阴性,多数预后良好但少数可复发或进展为淋巴瘤。

要点

  • pmCD30+TLPD多见于口腔黏膜,形态多样,易误诊为原发皮肤CD30+TLPD或系统性ALK阴性ALCL。
  • 肿瘤细胞CD30均匀强阳性,ALK和CD56阴性,EBER阴性,TCR克隆性仅部分阳性。
  • 多数病例预后良好,但少数可复发或进展为淋巴瘤,需长期随访。

核心结论

  • pmCD30+TLPD形态学谱系宽,易与原发皮肤CD30+TLPD及累及黏膜的系统性ALK阴性间变性大细胞淋巴瘤混淆而误诊。
  • 多数病例预后良好,少数病例复发或进展为淋巴瘤。

研究设计与样本

  • 回顾性收集首都医科大学附属北京友谊医院及北京陆道培医院2013至2023年会诊的8例pmCD30+TLPD。
  • 检测免疫表型、EB病毒感染状态和T细胞受体克隆性,分析临床病理特征并复习文献。

主要发现

  • 患者女性5例、男性3例,年龄28~73岁,均无B症状,缺乏创伤和自身免疫性疾病。
  • 7例发生于口腔黏膜,1例为肛管黏膜;所有病例表现为黏膜结节,除1例外均伴溃疡。
  • 异型淋巴细胞表达CD3(7/8)、CD4+/CD8-(7/8)、CD4-/CD8-(1/8)。
  • CD30均匀强阳性,不表达ALK和CD56;EBER原位杂交阴性5/5例;TCR基因重排阳性2例。
  • 4例未进行放化疗;除1例因同时伴有白细胞减少症死亡外,7例均无病生存。

关键数值与推荐

  • CD30均匀强阳性,ALK和CD56阴性,EBER阴性5/5例。
  • TCR基因重排阳性2例。
  • 4例未接受放化疗,7例无病生存,1例死亡与并发白细胞减少症相关。

临床怎么用

  • 诊断pmCD30+TLPD需结合形态学、CD30强阳性、ALK和CD56阴性及EBER阴性,注意与原发皮肤CD30+TLPD和系统性ALK阴性ALCL鉴别。
  • 多数病例预后良好,但少数可复发或进展为淋巴瘤,应长期随访。

局限性

  • 回顾性研究,样本量仅8例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the clinicopathological features and differential diagnosis of primary mucosal CD30-positive T-cell lymphoproliferative disorders (pmCD30+TLPD). Methods: Eight cases of pmCD30+TLPD diagnosed from 2013 to 2023 at the Department of Pathology, Beijing Friendship Hospital Affiliated to Capital Medical University and Beijing Ludaopei Hospital were retrospectively collected. The immunophenotype, EBV infection status and T-cell receptor (TCR) clonability of tumor cells were examined. The clinicopathological features were analyzed and related literatures were reviewed. Results: There were 5 females and 3 males, aged 28 to 73 years, without B symptoms, lack of trauma and autoimmune diseases. Seven cases occurred in oral mucosa and one in anal canal mucosa. Submucosal nodules with ulcerations were presented in all cases except one, which only submucosal nodule. Morphologically, there was different distribution of allotypic lymphocytes in inflammatory background. Four cases showed "kidney-shaped", "embryonic" and "horseshoe-shaped" cells, and one case resembled Hodgkin and Reed/Sternberg (HRS) cells. Allotypic lymphocytes expressed CD3 (7/8), CD4+/CD8-(7/8) and CD4-/CD8-(1/8). CD30 was uniformly strongly positive while ALK and CD56 were negative. In situ hybridization of EBER was negative in five cases (5/5). Clonal TCR gene rearrangement was positive in two cases. Four patients did not receive radiotherapy or chemotherapy. All the seven patients survived without disease except one died due to concurrent leukopenia. Conclusions: pmCD30+TLPD had a broad morphological spectrum and could be easily confused with primary cutaneous CD30+TLPD and systemic ALK-negative anaplastic large cell lymphoma involving mucosa, which may lead to misdiagnosis. Although the majority of the cases had a favorable prognosis, a few cases relapsed or progressed to lymphoma. 目的: 探讨原发黏膜CD30阳性T细胞淋巴组织增殖性疾病(pmCD30+TLPD)的临床病理特征及鉴别诊断。 方法: 回顾性收集首都医科大学附属北京友谊医院及北京陆道培医院2013至2023年会诊的8例pmCD30+TLPD,检测该病的免疫表型、EB病毒感染状态和T细胞受体(TCR)克隆性,分析患者的临床病理特征并复习相关文献。 结果: 患者男性3例,女性5例,年龄28~73岁;均无B症状,缺乏创伤和自身免疫性疾病。7例发生于口腔黏膜,1例为肛管黏膜。所有病例表现为黏膜结节,除1例外均伴溃疡。形态学上,于炎性背景中分布多少不等的异型淋巴细胞,4例呈“肾形”“胚胎样”及“马蹄铁样”细胞;1例类似霍奇金淋巴瘤HRS细胞。异型淋巴细胞表达CD3(7/8)、CD4+/CD8-(7/8)、CD4-/CD8-(1/8);CD30均匀强阳性,不表达间变性淋巴瘤激酶(ALK)和CD56。5/5例EB病毒原位杂交阴性。2例TCR基因重排阳性。4例未进行放化疗。除1例因同时伴有白细胞减少症而死亡外,7例均无病生存。 结论: pmCD30+TLPD形态学谱系较宽,容易与原发皮肤CD30阳性T细胞淋巴组织增殖性疾病和累及黏膜的系统性ALK阴性间变性大细胞淋巴瘤相混淆,从而造成误诊。预后良好,少数病例复发或进展为淋巴瘤。.

来源:Zhonghua Bing Li Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Dong N, Zhang LN, Zheng YY, et al. [Clinicopathological features of primary mucosal CD30-positive T-cell lymphoproliferative disorders]. Zhonghua Bing Li Xue Za Zhi. 2024. PMID: 38955696. doi:10.3760/cma.j.cn112151-20240115-00038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。